Credit Suisse’s Kalaris Therapeutics KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $113K | Sell |
|
|||||
|
2023
Q2 | $189K | Buy |
|
|||||
|
2023
Q1 | $165K | Buy |
|
|||||
|
2022
Q4 | $191K | Buy |
|
|||||
|
2022
Q3 | $239K | Buy |
|
|||||
|
2022
Q2 | $98K | Buy |
|
|||||
|
2022
Q1 | $164K | Buy |
|
|||||
|
2021
Q4 | $293K | Sell |
|
|||||
|
2021
Q3 | $667K | Buy |
|
|||||
|
2021
Q2 | $361K | Buy |
|
|||||
|
2021
Q1 | $258K | Sell |
|
|||||
|
2020
Q4 | $991K | Buy |
|